{[3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}amine, 95.0%, 10g

2-Chloro-1-(2-phenyl-1h-indol-3-yl)ethan-1-one, 95%, 250mg

(3-(Benzyloxy)pyridin-4-yl)methanamine hydrochloride, 5g

3-Methylthiophene-2-carbonitrile, 96.0%, 25g

2-Acetylindole, 95.0%, 250mg

1-Benzyl-4-bromo-1H-imidazole, 95.0%, 250mg

5-Fluoroisatin, 97.0%, 5g

2-Chloro-n-(diphenylmethyl)propanamide, 97%, 250mg

2-Fluoro-3-chlorophenylhydrazine hydrochloride, 95.0%, 10g

1-Allylindoline-2,3-dione, 95.0%, 250mg

Fase de planificación PLPHi S100x/1,25 objetivo IOS de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm

2-(Methylthio)benzoic acid, 97.0%, 1g

1-(4-Bromophenyl)-2-oxopyrrolidine-3-carboxylic acid, 250mg